Medis
@medis.is
Medis specializes in out-licensing high-quality generic pharmaceuticals to third-party pharmaceutical companies. Established in 1985, we offer a broad portfolio of 200+ generic pharmaceutical products, mainly in the form of tablets, capsules and injections. Our portfolio includes a growing range of specialist oncology products and product formulations, predominantly solid oral dosages. We develop these products in house and provide our customers with the necessary regulatory support. In fact, we have a proven track record in securing regulatory approval prior to patent expiries, and have supported our customers in obtaining marketing authorizations in over 100 countries. Medis has full backing from our parent company, Teva Pharmaceutical Industries Ltd. We draw on their development and manufacturing capabilities, and their team of in-house experts. At the same time, our focus on technical excellence and compliance extends to our treatment of our customers confidential information. At Medis, we pride ourselves on our longevity and our loyalty. For over 41 years, we have built strong and lasting relationships with our customers, and we are confident that these relationships will only be enhanced going forward.
Medis's Company Logos
Medis's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#D71635
Crimson
215, 22, 53
350, 81, 46
0, 90, 75, 16
#DCE4EB
Mystic
220, 228, 235
208, 27, 89
6, 3, 0, 8
#0D3360
Madison
13, 51, 96
213, 76, 21
86, 47, 0, 62
About Medis
Medis is a reliable and established brand that specializes in out-licensing high-quality generic pharmaceuticals to third-party pharmaceutical companies. With over 38 years of experience, Medis has built strong and lasting relationships with its customers, offering a vast generics portfolio and comprehensive regulatory support. Their broad portfolio includes 185 generic pharmaceutical products, primarily in the form of tablets, capsules, and injections, with a focus on specialist oncology products and formulations.
Medis develops these products in-house and provides customers with the necessary regulatory support, having obtained marketing authorizations in over 140 countries. As part of Teva Pharmaceutical Industries Ltd., Medis leverages their parent company's expertise in development and manufacturing. Medis also emphasizes technical excellence and compliance, ensuring the utmost confidentiality of customers' information.
Through effective communication and dedicated customer support, Medis aims to optimize the customer experience and maintain strong partnerships in the pharmaceutical industry. With manufacturing sites meeting the highest international standards, Medis is committed to sustainability and reducing its environmental impact. Headquartered in Iceland, Medis has a global presence, serving markets in Europe, Eastern Europe, Latin America, and Asia.
Contact Medis today to learn more about their high-quality products and services
Company type
Public Company
Year founded
1985
Company size
51-200 employees
